A Search for Inhibitors of S100B, a Member of the S100 Family of Calcium-Binding Proteins
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
7
Page:
609-616
Author(s):
Joseph Markowitz, Alexander D. MacKerell and David J. Weber
Angiogenesis and Metastasis Inhibitors for the Treatment of Malignant Melanoma
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
7
Page:
649-661
Author(s):
Riichiro Abe, Yasuyuki Fujita and Sho-ichi Yamagishi
Design, Synthesis and Biological Evaluation of Ligands Selective for the Melanocortin-3 Receptor
Journal:
Current Topics in Medicinal Chemistry
Volume:
7
Page:
1085-1097
Author(s):
Matthew M. Dedek, Devendra Trivedi, Alexander V. Mayorov, James P. Cain, Minying Cai and Victor J. Hruby
The Brain Galanin Receptors: Targets for Novel Antidepressant Drugs
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
6
Page:
183-192
Author(s):
Xiaoying Lu, Lisa Sharkey and Tamas Bartfai
Secondary Metabolites from Cordyceps Species and Their Antitumor Activity Studies
Journal:
Recent Patents on Biotechnology
Volume:
1
Page:
123-137
Author(s):
Jian-Hui Xiao and Jian-Jiang Zhong
Effect of Flavonoids on Human Health: Old Subjects but New Challenges
Journal:
Recent Patents on Biotechnology
Volume:
1
Page:
139-150
Author(s):
Eung-Ryoung Lee, Geun-Ho Kang and Ssang-Goo Cho
Plasmid DNA Manufacturing Technology
Journal:
Recent Patents on Biotechnology
Volume:
1
Page:
151-166
Author(s):
Aaron E. Carnes and James A. Williams
Patents on Immunotoxins and Chimeric Toxins for the Treatment of Cancer
Journal:
Recent Patents on Drug Delivery & Formulation
Volume:
1
Page:
105-115
Author(s):
Christopher Bachran, Mark Sutherland, Diana Bachran and Hendrik Fuchs
Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels
Journal:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Volume:
1
Page:
103-118
Author(s):
Michael L. Mohler, Ramesh Narayanan, Yali He, Duane D. Miller and James T. Dalton
Melatonin and Melatoninergic Drugs as Therapeutic Agents: Ramelteon and Agomelatine, the Two Most Promising Melatonin Receptor Agonists
Journal:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Volume:
1
Page:
142-151
Author(s):
Emilio J. Sanchez-Barcelo, Carlos M. Martinez-Campa, Maria D. Mediavilla, Alicia Gonzalez, Carolina Alonso-Gonzalez and Samuel Cos